Caption Management, LLC Atai Life Sciences N.V. Transaction History
Caption Management, LLC
- $10.8 Billion
- Q3 2025
A detailed history of Caption Management, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Caption Management, LLC holds 42,500 shares of ATAI stock, worth $175,525. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,500Holding current value
$175,525% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ATAI
# of Institutions
141Shares Held
38.9MCall Options Held
1.74MPut Options Held
525K-
Ubs Group Ag7.68MShares$31.7 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$22.4 Million0.05% of portfolio
-
Morgan Stanley New York, NY4.82MShares$19.9 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.58MShares$10.6 Million0.0% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY2.29MShares$9.45 Million12.47% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $685M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...